Compare Bitwise Crypto Industry Innovators ETF (BITQ) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitwise Crypto Industry Innovators ETF vs TG Therapeutics Inc — how do they compare? Bitwise Crypto Industry Innovators ETF trades at $23.58, while TG Therapeutics Inc trades at $54.84 (market cap $8.42B). The key difference: TG Therapeutics Inc is trading nearer its 52-week high, Bitwise Crypto Industry Innovators ETF nearer its low. Which is the better fit depends on your goals.
| BITQ | TGTX | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $30.43 | $59.06 |
52-Week Low | $16.74 | $26.39 |
Market Cap | — | $8.42B |
Enterprise Value | — | $8.66B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bitwise Crypto Industry Innovators ETF
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
